La sperimentazione animale in Europa: l’incidenza della Direttiva 2010/63 UE tra gli Stati membri e il suo ruolo nello sviluppo del vaccino anti Covid-19

Autori

  • Mariangela Barletta

DOI:

https://doi.org/10.15168/2284-4503-808

Parole chiave:

Animal testing, Covid-19 vaccine, Directive 2010/63/UE, Legislative decree n. 26/2014, 3Rs principles

Abstract

The article wishes to analyze the impact of the Directive 2010/63 in the EU related to animal welfare, taking also into account the actual question about Covid-19 vaccines. The Directive aims to develop animal welfare and to harmonize states legislation in this field. For this purpose, the European Union encourages States to develop new research methods in order to replace and reduce the use of animals or, at least, to refine methods in which they should be used. Many states have correctly implemented the Directive, but some still are under the infraction procedures by the European Commission; for instance, Italy, due its more restrictive measures.

##submission.downloads##

Pubblicato

2021-06-17

Come citare

1.
Barletta M. La sperimentazione animale in Europa: l’incidenza della Direttiva 2010/63 UE tra gli Stati membri e il suo ruolo nello sviluppo del vaccino anti Covid-19. BioLaw [Internet]. 17 giugno 2021 [citato 29 marzo 2024];(2):41-59. Available at: https://teseo.unitn.it/biolaw/article/view/1695

Fascicolo

Sezione

Call for papers